Journal of Medicinal Chemistry (JMC) is excited to announce the appointment of its Early Career Advisory Board. The new Early Career Advisory board features over a dozen young researchers with a variety of expertise from across the globe. They will work with journal Editor-in-Chief Professor Craig Lindsley and its Associate Editors by sharing their perspectives […]

Personally, becoming a member of the JMC Early Career Board will allow me to better follow the hot topics in the field of medicinal chemistry, and provide the opportunity to meet and communicate with the distinguished young medicinal chemists from all over the world, which is very beneficial to my scientific research career. At the other hand, I hope to promote the outstanding research work of Chinese scientists and help to enhance the academic influence of Chinese scientists worldwide. Hope to make my modest effort in the future work.

<strong>Paul C. Trippier, </strong><strong>Director, Pharmaceutical Sciences Graduate Program, </strong><strong>University of Nebraska Medical Center</strong>

The Journal of Medicinal Chemistry is the most prestigious in our field. I am excited to play a small part in continuing this tradition and steering the journal forward. I see serving on the Early Career Board as an opportunity to reach out to new talent in the field, bring them into the collection of amazing scientists who publish in the journal and to increase collaborations with the ACS MEDI Division.

<strong>Fleur M. Ferguson, William A. Lee Assistant Professor, Department of Chemistry & Biochemistry</strong>

I’m incredibly excited to join the JMC Early Career Board! I am looking forward to learning more about the publishing and editorial process, and collaborating with an outstanding international team of early-career scientists and the editorial board to shape the future of JMC.

I hope to contribute by working with the Early Career Board to identify and highlight important research advances and emerging themes, particularly those at the interface of chemical biology and medicinal chemistry. In addition, I hope to bring an early-career perspective to journal policy issues.

<strong>Deepak B. Salunke, </strong><strong>Assistant Professor and Ramalingaswami Fellow,</strong> <strong>India Department of Biotechnology</strong>, <strong>Coordinator, National Interdisciplinary Centre of Vaccine, Immunotherapeutics and Antimicrobials, Department of Chemistry, Panjab University, Chandigarh</strong>

Being a Journal of Medicinal Chemistry early career board member is an exciting opportunity. A journey with diverse group of young minds with an experienced and qualified leadership will definitely be a super learning experience. While working for the journal to recruit high-quality submissions and carry out other related activities, I am very much interested to use this opportunity to build a discussion/interaction platform of expert medicinal chemists at India and compile yearly virtual issues showcasing the medicinal chemistry happening in India at both academia as well as at the industrial settings. There are many good organic chemists in academia and their transformation via building good discovery working groups and medicinal chemistry platforms is definitely required. Development of a new trend medicinal chemistry curriculum for master students at the recently initiated National Interdisciplinary Centre of Vaccine, Immunotherapeutics and Antimicrobials at the Panjab University, Chandigarh is another short-term goal. This association with the JMC and other expert board members will be very useful and crucial towards this direction. I also would like to take this opportunity and coordinate yearly international meetings where experts from all over the world can showcase the research activities at the interface of chemistry and biology to educate the young minds towards the exciting field of Medicinal Chemistry.

<strong>Amanda L. Garner, </strong><strong>Associate Professor, </strong><strong>College of Pharmacy, </strong><strong>Department of Medicinal Chemistry, </strong><strong>University of Michigan</strong>

I am excited to be a part of the JMC Early Career Board to be able to provide insights into the future of the journal. My research spans chemical biology and medicinal chemistry, and I am looking forward to serving as a bridge between these fields to expand the content and readership of JMC. Moreover, as a woman in medicinal chemistry, I am especially eager to provide new ways to highlight the important contributions of women to the field to inspire our next generation of female medicinal chemists.

<strong>Caitlin Kent, </strong><strong>Scientist, Sanofi</strong>

I’m honored and excited to be part of such an impressive group of young medicinal chemists and represent industry within the Early Career Board. I hope my participation within the Early Career Board and other journal matters will ultimately influence the content and medicinal chemistry stories that train future generations of medicinal chemists.

<strong>Pedro M. Garcia Barrantes, </strong><strong>Research Scientist II, </strong><strong>Vertex Pharmaceuticals</strong>

I am honored to be part of the Early Career Board. JMC is a unique journal, the staple publication in the field, and I am thrilled to be part of the team that makes it happen. This board is a great initiative and I am impressed by the enthusiasm and the diversity of backgrounds of the selected scientists, I believe everyone bring something especial to the board. I look forward to collaborating with other members to provide the perspective of a younger scientist audience.

I believe the journal plays a significant role in educating the next generation of medicinal chemists. I have been reading JMC since before I decided to be a med chemist, and it has had an enormous impact on my training. I would like to contribute to keep the high scientific quality of the journal, bringing topics that are fresh, current and of interest to the drug discovery community, and by attracting and facilitating the publication of ground-breaking discoveries. I believe that if we work hard on this, we will continue to have an impact in the field and towards the drug discovery’s endgame, the development of new treatments for patients in need.

<strong>Benita Sjogren, </strong><strong>Assistant Professor of Medicinal Chemistry and Molecular Pharmacology, </strong><strong>Purdue University</strong>

It is an honor to join the JMC Early Career Board. As a member I hope to help narrow the gap between biologists and medicinal chemists in early drug discovery. I look forward to working with the members of the JMC Early Career Board to increase visibility for the journal, and help guide where it will go in the future.

<strong>Marie-Gabrielle Braun, </strong><strong>Genentech, Inc.</strong>

I am very excited to be part of the JMC Early Career Board as JMC is the most trusted and cited medicinal chemistry journal in the world. I hope to bring my industrial experience to contribute to the journal’s visibility by further expanding its scope, authorship, and impact. I want JMC to be the first choice for early career researchers to publish their medicinal chemistry research so that their research gets the most visibility across the community. In addition, I hope to address gender and ethnicity parity issues by supporting women and minorities who work in medicinal chemistry.

<strong>Eufrânio N. da Silva Júnior, Professor of Organic Chemistry, Institute of Exact Sciences, Department of Chemistry</strong>

<strong>Christian W. Gruber, Associate Professor, </strong><strong>Drug Discovery and Peptidomics, </strong><strong>Medical University of Vienna </strong><strong>Center for Physiology and Pharmacology</strong>

I am excited to serve on the JMC Early Career Board to contribute to the publication of high quality manuscripts in the top journal of its field. During my term I would like to help shape the future of Medicinal Chemistry, by suggesting themed issues or perspectives, and by building links between young scientists and the leaders in the field.

<strong>Haruto Kurata, Senior Scientist, Medicinal Chemistry Research Laboratories</strong>

I am so excited about interacting with various scientists all over the world through my role as a member of the JMC Early Career Board. I would like to influence early career medicinal chemists through my expertise in the field, which I hope leads to promoting JMC. I also plan to contribute to promoting cultural diversity, which I believe is very important to enhancing science.

<strong>Carles Galdeano, Serra Hunter Lecturer Professor, University of Barcelona</strong>

Since the beginning of my research career in drug discovery and medicinal chemistry I have considered JMC the reference journal in the field. The opportunity to contribute to build the reputation and keep the excellence of the journal as a member of the Early Career Board is very thrilling. The JMC Early Career Board is made up of young but top-level scientist from around the world. I hope that we can work together, in a synergistic manner, to help high-quality and innovative science to be publish efficiently in JMC. In parallel, I would like to help to increase the visibility of early career researchers in our field promoting different initiatives.

I was thrilled at being named a part of the JMC Early Career Board. To me, the JMC is not only the most trusted and cited medicinal chemistry journal in the world, but also a valued source where to find the latest cutting-edge advances in drug discovery and useful content that supports my day-to day training as medicinal chemist. I owe the JMC a great deal for tremendously developing the field over the years and aiding me in getting better at my job.

As a member of the JMC Early Career Board, I am eager to bring to this role both industrial and academic experience and positively contribute to the growth of this prestigious journal. I am committed to retaining and expanding the legacy of JMC, ensuring a fair and transparent publishing process, as well as supporting the journal to broaden and diversify its scope, in terms of scientific content and key players, such as readers, authors, and reviewers, to strengthen the research community.

<strong>Federica Prati, </strong><strong>Medicinal Chemistry Scientist, </strong><strong>Presso Angelini Pharma</strong>

I was thrilled at being named a part of the JMC Early Career Board. To me, the JMC is not only the most trusted and cited medicinal chemistry journal in the world, but also a valued source where to find the latest cutting-edge advances in drug discovery and useful content that supports my day-to day training as medicinal chemist. I owe the JMC a great deal for tremendously developing the field over the years and aiding me in getting better at my job.

As a member of the JMC Early Career Board, I am eager to bring to this role both industrial and academic experience and positively contribute to the growth of this prestigious journal. I am committed to retaining and expanding the legacy of JMC, ensuring a fair and transparent publishing process, as well as supporting the journal to broaden and diversify its scope, in terms of scientific content and key players, such as readers, authors, and reviewers, to strengthen the research community.

<strong>Mariateresa Giustiniano, Assistant Professor, </strong><strong>University of Naples Federico II | UNINA · Department of Pharmacy</strong>

I am very grateful and excited to serve as a member of the Early Career Board of JMC, the leading journal in disseminating the most important advances in drug discovery! I am looking forward to working with my colleagues to assist the Editorial Board at my best and to share ideas aimed at promoting the training and the interests of the younger generations of medicinal chemists.

<strong>Yimon Aye, Swiss Federal Institute of Technology Lausanne (EPFL)</strong>

My laboratory develops original chemical biology tools with which to solve challenging research problems in the broader fields of biological stress regulation and genome maintenance. Both areas are a treasure trove offering untapped opportunities for drug discovery, in alignment with the spirit of medicinal chemistry research. As a scientist trained in both organic chemistry and classical enzymology, I am enthusiastic to help promote Journal’s ongoing and future efforts, particularly those involving interdisciplinary knowhow.
[/expand]

<strong>Damian W. Young, Assistant Professor, Baylor College of Medicine, Depart of Pharmacology and Chemical Biology</strong>

I am honored to be a member of the JMC Early Career Board. JMC was actually the first scientific journal that I was exposed to as an undergraduate student during my first summer internship at GD Searle and Company. As I read articles, I can still recall how excited I was to connect the new passion that I had found for synthetic organic chemistry with molecules that possessed biological activity. Fast forward to the present, I am excited to be a part of the Early Career Board and to provide my insight about future directions of this important journal. Given that I work within a medical college instead of a traditional chemistry department I hope to provide views for the journal that are relevant to translation.

Want the latest stories delivered to your inbox each month?